Mucosal vaccine-induced cross-reactive CD8<sup>+</sup> T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.

Nat Immunol · 2024 · PMC10907304 · PMID 38337035

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Immunization with monovalent ChAd-SARS-CoV-2-S or bivalent ChAd vaccines protected against weight loss after XBB.1.5 infection, but the differences did not reach statistical significance (Fig. 6d ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.